ProfileGDS4718 / 237362_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 69% 71% 68% 71% 69% 69% 69% 69% 72% 73% 69% 69% 72% 72% 71% 70% 68% 71% 68% 67% 70% 71% 70% 69% 69% 70% 67% 66% 66% 72% 71% 69% 70% 71% 71% 67% 75% 69% 69% 66% 69% 72% 70% 73% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.7824469
GSM549102patient 115, normal, homogenized [OPG study]6.9573271
GSM549104patient 119, normal, homogenized [OPG study]6.7904768
GSM549108patient 138, normal, homogenized [OPG study]6.9468171
GSM549119patient 077, normal, homogenized [OPG study]6.8035169
GSM549133patient 032, cancer, homogenized [OPG study]6.8240869
GSM549139patient 042, cancer, homogenized [OPG study]6.8118269
GSM549099patient 107, normal, homogenized [OPG study]6.7409869
GSM549109patient 139, normal, homogenized [OPG study]7.0331272
GSM549110patient 046, normal, homogenized [OPG study]7.0990173
GSM549114patient 063, normal, homogenized [OPG study]6.7527669
GSM549122patient 082, normal, homogenized [OPG study]6.8264669
GSM549134patient 033, cancer, homogenized [OPG study]7.0530172
GSM549136patient 036, cancer, homogenized [OPG study]7.1285772
GSM549140patient 044, cancer, homogenized [OPG study]6.9631771
GSM549111patient 047, normal, homogenized [OPG study]6.8876470
GSM549113patient 057, normal, homogenized [OPG study]6.6861968
GSM549132patient 031, cancer, homogenized [OPG study]6.9653671
GSM549137patient 038, cancer, homogenized [OPG study]6.7568668
GSM549142patient 047, cancer, homogenized [OPG study]6.6713867
GSM549100patient 110, normal, homogenized [OPG study]6.8323370
GSM549107patient 135, normal, homogenized [OPG study]6.921271
GSM549115patient 068, normal, homogenized [OPG study]6.9048970
GSM549116patient 072, normal, homogenized [OPG study]6.8044369
GSM549120patient 078, normal, homogenized [OPG study]6.7900169
GSM549131patient 030, cancer, homogenized [OPG study]6.94570
GSM549118patient 074, normal, homogenized [OPG study]6.6165967
GSM549129patient 027, cancer, homogenized [OPG study]6.5811766
GSM549123patient 088, normal, homogenized [OPG study]6.5624866
GSM549124patient 006, cancer, homogenized [OPG study]7.0112872
GSM549126patient 015, cancer, homogenized [OPG study]6.9686171
GSM549128patient 025, cancer, homogenized [OPG study]6.8267269
GSM549103patient 117, normal, homogenized [OPG study]6.8425370
GSM549117patient 073, normal, homogenized [OPG study]6.8704971
GSM549138patient 041, cancer, homogenized [OPG study]6.9599271
GSM549141patient 045, cancer, homogenized [OPG study]6.7052267
GSM549130patient 028, cancer, homogenized [OPG study]7.3467875
GSM549101patient 111, normal, homogenized [OPG study]6.8110569
GSM549105patient 128, normal, homogenized [OPG study]6.7805369
GSM549106patient 134, normal, homogenized [OPG study]6.6023866
GSM549112patient 048, normal, homogenized [OPG study]6.7835269
GSM549125patient 011, cancer, homogenized [OPG study]7.0115672
GSM549127patient 024, cancer, homogenized [OPG study]6.9916170
GSM549135patient 035, cancer, homogenized [OPG study]7.235573